Skip to main content

Table 2 Prescriptions of biologicals for rheumatoid arthritis under the PBS and RPBS by Australian States and Territories based on aggregate data, Aug 2003–Jul 2005

From: The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines

  NSW VIC QLD SA WA TAS ACT NT TOTAL
Number of prescriptions          
Etanercept 7 559 3 685 2 205 3 064 2 142 1 085 939 63 20 742
Infliximaba 190 182 146 51 280 2 0 0 851
Adalimumab 1 842 1 496 1 096 503 820 369 116 15 6 257
Anakinra 52 17 25 8 17 0 1 0 120
Biologicals Total 9 643 5 380 3 472 3 626 3 259 1 456 1 056 78 27 970
Biologicals Prescriptions per 10,000 populationb 14.4 10.9 9.0 23.7 6.6 30.3 32.7 3.9  
Number of rheumatologistsc 86 69 32 29 24 5 5 2  
Rheumatologists per 10,000 population 0.128 0.139 0.083 0.189 0.122 0.104 0.155 0.100  
Biologicals Prescriptions per rheumatologist 112.1 78.0 108.5 125.0 135.8 291.2 211.2 39  
  1. Note:
  2. a Number of prescriptions of infliximab: usage in public hospital is not included in the statistical report by Medicare Australia.
  3. b Source: Australian Bureau of Statistics, Australian Population – States and Territories, December quarter, 2003.
  4. c Number of rheumatologists registered as members of the Australian Rheumatology Association
  5. Australian states and territories: NSW = New South Wales, VIC = Victoria, QLD = Queensland, SA = South Australia, WA = Western Australia, TAS = Tasmania, ACT = Australian Capital Territory, NT = Northern Territory